Prevalence and severity of depression, anxiety, stress and perceived stress in hospitalized patients with COVID-19

Atefeh Zandifar, Rahim Badrfam, Shahrooz Yazdani, Seyed Masoud Arzaghi, Fatemeh Rahimi, Somayeh Ghasemi, Somayeh Khamisabadi, Nami Mohammadian Khonsari, Mostafa Qorbani, Atefeh Zandifar, Rahim Badrfam, Shahrooz Yazdani, Seyed Masoud Arzaghi, Fatemeh Rahimi, Somayeh Ghasemi, Somayeh Khamisabadi, Nami Mohammadian Khonsari, Mostafa Qorbani

Abstract

Purpose: COVID-19, a disease that can be transmitted from person to person and with serious health problems, can be associated with mental health disorders. In this study, we evaluated the prevalence and severity of depression, anxiety, stress, and stress perception among a group of patients with COVID-19 who were hospitalized.

Methods: In this cross-sectional study, 106 inpatients with COVID-19 who had stable clinical conditions were evaluated psychologically by two questionnaires: Depression, Anxiety and Stress Scales-21 (DASS-21) and Perceived Stress Scale (PSS-4).

Results: More than one third of patients had underlying disease. Overall, 97.2% of patients with COVID-19 had some degree of depression. Severity of depression, according to the DASS questionnaire, was 85.8%. All patients (100%) had severe (0.9%) and very severe (99.1%) anxiety. Regarding to stress levels, 97.1% of patients had some degree of stress. In the severity of stress category, 84.9% of patients had severe and very severe stress. In terms of perceived stress, 73.6% of patients had high levels and 22.6% had moderate levels. A positive strong correlation was found between depression and perceived stress (Coefficient: 0.33, P-value: 0.001). Correlation between anxiety and perceived stress was statistically significant (Coefficient: 0.2, P-value: 0.04).

Conclusions: The existence of such a high prevalence and severity of psychiatric disorders among hospitalized patients with COVID-19 underscores the need for serious attention to the mental health status of these patients. It seems that health policymakers need to have coherent plans for screening cases and managing related situations.

Keywords: Anxiety; COVID-19; Depression; Management; Patients; Stress.

Conflict of interest statement

Conflicts of interest/Competing interests There is no conflict of interest.

© Springer Nature Switzerland AG 2020.

Figures

Fig. 1
Fig. 1
Mean of depression, anxiety and stress score and total perceived stress scale score in hospitalized patients with COVID-19
Fig. 2
Fig. 2
Prevalence of severe depression, anxiety and stress in hospitalized patients with COVID-19

References

    1. Li W, et al. Progression of Mental Health Services during the COVID-19 Outbreak in China. Int J Biol Sci. 2020;16(10):1732.
    1. Database2020b, Database2020a. World Health Organization, speeches, March 11,2020. Available from ..
    1. Database2020a, Database2020k. World Health Organization, speeches, January30,2020. Available from .
    1. Ransing R, et al. Early career psychiatrists’ perspectives on the mental health impact and care of the COVID-19 pandemic across the world. Asian J Psychiatry, 2020:102085.
    1. Badrfam R, Zandifar A. Stigma Over COVID-19; New conception beyond individual sense. Arch Med Res. 2020;51(6):593–594.
    1. Badrfam R, Zandifar A. COVID-19 and melancholia; Different perception of the concept of stigma and loss. Iran J Psychiatry. 2020;15(3):264–5.
    1. Bo HX, Li W, Yang Y, Wang Y, Zhang Q, Cheung T, et al. Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China. Psychol Med. 2020. 10.1017/S0033291720000999.
    1. Zandifar A, Badrfam R. Iranian mental health during the COVID-19 epidemic. Asian J Psychiatry. 2020;51:101990.
    1. Xiang Y-T, et al. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry. 2020;7(3):228–9.
    1. Zandifar A, Badrfam R, Khonsari NM, Assareh M, Karim H, Azimzadeh M, et al. COVID-19 and medical staff’s mental health in educational hospitals in Alborz Province, Iran. Psychiatry Clin Neurosci. 2020. 10.1111/pcn.13098.
    1. Zandifar A, et al. Prevalence and associated factors of posttraumatic stress symptoms and stigma among health care workers in contact with COVID-19 patients. Iran J Psychiatry. 2020;15(4):355–65.
    1. Maunder R, et al. The immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospital. Cmaj. 2003;168(10):1245–51.
    1. Lima CKT, et al. The emotional impact of Coronavirus 2019-nCoV (new Coronavirus disease) Psychiatry Res. 2020;287:112915.
    1. Duan L, Zhu G. Psychological interventions for people affected by the COVID-19 epidemic. Lancet Psychiatry. 2020;7(4):300–2.
    1. Zheng W. Mental health and a novel coronavirus (2019-nCoV) in China. J Affect Disord. 2020;269:201–202.
    1. Sandström YK, et al. Psychiatric comorbidities in patients with hypertension–a study of registered diagnoses 2009–2013 in the total population in Stockholm County, Sweden. J Hypertens. 2016;34(3):414–20.
    1. Lankarani MM, Assari S. Association between number of comorbid medical conditions and depression among individuals with diabetes; race and ethnic variations. J Diabetes Metab Disord. 2015;14(1):56.
    1. Norton PJ. Depression Anxiety and Stress Scales (DASS-21): Psychometric analysis across four racial groups. Anxiety Stress Coping. 2007;20(3):253–65.
    1. Asghari A, Saed F, Dibajnia P. Psychometric properties of the Depression Anxiety Stress Scales-21 (DASS-21) in a non-clinical Iranian sample. Int J Psychol. 2008;2(2):82–102.
    1. Antony MM, et al. Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample. Psychol Assess. 1998;10(2):176.
    1. Leung DY, Lam T-h, Chan SS. Three versions of Perceived Stress Scale: validation in a sample of Chinese cardiac patients who smoke. BMC Public Health. 2010;10(1):513.
    1. Maroufizadeh S, Zareiyan A, Sigari N. Psychometric properties of the 14, 10 and 4-item “Perceived Stress Scale” among asthmatic patients in Iran. Payesh (Health Monitor) 2014;13(4):457–65.
    1. Cohen S. Perceived stress in a probability sample of the United States. 1988.
    1. Cao C, Li Y, Liu S, Fan H, Hao L. Epidemiologic features of 135 patients with coronavirus disease (COVID-19) in Tianjin, China. Disaster Med Public Health Prep. 2020;1:1–5. 10.1017/dmp.2020.63.
    1. Lorant V, et al. Socioeconomic inequalities in depression: a meta-analysis. Am J Epidemiol. 2003;157(2):98–112.
    1. Torales J, et al. The outbreak of COVID-19 coronavirus and its impact on global mental health. Int J Soc Psychiatry. 2020;66(4):317–320.
    1. Gupta M, Abdelmaksoud A, Jafferany M, Lotti T, Sadoughifar R, Goldust M. COVID-19 and economy. Dermatol Ther. 2020;33:e13329. 10.1111/dth.13329.
    1. Zandifar A, Badrfam R. Fighting COVID-19 in Iran; Economic challenges ahead. Arch Iran Med. 2020;23(4):284.
    1. Mohammadi MR, et al. Social capital in general population of Tehran province in comparison with other provinces of Iran. J Iran Med Counc. 2019;2(3):26–34.
    1. Ta VP, et al. Stress of singlehood: Marital status, domain-specific stress, and anxiety in a national US sample. J Soc Clin Psychol. 2017;36(6):461–85.
    1. Emami A, et al. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020;8(1):e35.
    1. Covid C, et al. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019—United States, February 12–March 28, 2020. Morb Mortal Wkly Rep. 2020;69(13):382.
    1. Sartorious N. Comorbidity of mental and physical diseases: a main challenge for medicine of the 21st century. Shanghai Arch Psychiatry. 2013;25(2):68.
    1. Lim J, et al. Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. J Korean Med Sci. 2020;35(6):e79.
    1. Brooks SK, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395(10227):912–920.
    1. Okusaga O, et al. Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts. J Affect Disord. 2011;130(1–2):220–5.
    1. Zandifar A, Badrfam R. COVID-19; considering the prevalence of schizophrenia in the coming decades. Psychiatry Res. 2020;288:112982.
    1. Badrfam R, Zandifar A. From encephalitis lethargica to COVID-19: Is there another epidemic ahead? Clin Neurol Neurosurg. 2020;196:106065.
    1. Liu K, et al. Effects of progressive muscle relaxation on anxiety and sleep quality in patients with COVID-19. Complement Ther Clin Pract. 2020;39:101132.
    1. Seshadri S, Chatterjee BCM, Mukherjee A. Impact of COVID-19 pandemic on pre-existing mental health problems. Asian J Psychiatry. 2020;51:102071. Available online.
    1. Mirghaed MT, Gorji HA, Panahi S. Prevalence of psychiatric disorders in Iran: A systematic review and meta-analysis. Int J Prev Med. 2020;11:21.
    1. Noorbala AA, et al. Mental health survey of the Iranian adult population in 2015. Arch Iran Med. 2017;20(3):128–134.
    1. Pashaki MS, et al. The prevalence of comorbid depression in patients with diabetes: A meta-analysis of observational studies. Diabetes Metab Syndr Clin Res Rev. 2019;13(6):3113–9.
    1. Gandjalikhan-Nassab S-A-H, et al. Depression and anxiety disorders in a sample of facial trauma: A study from Iran. Med Oral Patol Oral Cir Bucal, 2016;21(4):e477-e482.
    1. Rosselli M, et al. Screening of distress among hospitalized patients in a department of internal medicine. Asian J Psychiatry. 2015;18:91–6.
    1. IsHak WW, et al. Screening for depression in hospitalized medical patients. J Hosp Med. 2017;12(2):118–25.
    1. Zatzick D, et al. A national US study of posttraumatic stress disorder, depression, and work and functional outcomes after hospitalization for traumatic injury. Ann Surg. 2008;248(3):429–37.
    1. Lee AM, et al. Stress and psychological distress among SARS survivors 1 year after the outbreak. Can J Psychiatry. 2007;52(4):233–40.
    1. Peeri NC, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol. 2020;49:717–726.
    1. Mak IWC, et al. Long-term psychiatric morbidities among SARS survivors. Gen Hosp Psychiatry. 2009;31(4):318–26.
    1. Davydow DS, et al. Psychiatric morbidity in survivors of the acute respiratory distress syndrome: a systematic review. Psychosom Med. 2008;70(4):512–9.
    1. Chua SE, et al. Stress and psychological impact on SARS patients during the outbreak. Can J Psychiatry. 2004;49(6):385–90.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner